Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Circulation | 15 May 2012
S Bangalore, S Kumar, M Fusaro, N Amoroso, MJ Attubato, F Feit, DL Bhatt and J Slater
Drug-eluting stents (DES) have been in clinical use for nearly a decade; however, the relative short- and long-term efficacy and safety of DES compared with bare-metal stents (BMS) and among the DES types are less well defined.
- Facebook likes*
- News coverage*
- SC clicks
- Hedge fund, Drug-eluting stent, Bare-metal stent, Randomized controlled trial, Coronary stent
- MeSH headings
- Aged, Angioplasty, Balloon, Coronary, Coronary Artery Disease, Coronary Restenosis, Drug-Eluting Stents, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, Male, Metals, Middle Aged, Paclitaxel, Randomized Controlled Trials as Topic, Registries, Risk Factors, Sirolimus, Time, Treatment Outcome, Tubulin Modulators
* Data courtesy of Altmetric.com